Photo by nci from unsplash
Mantle cell lymphoma (MCL) is an incurable aggressive non-Hodgkin lymphoma (NHL), which accounts for approximately 5% of all NHL. Novel agents and rituximab maintenance therapy (RM) have greatly improved patient… Click to show full abstract
Mantle cell lymphoma (MCL) is an incurable aggressive non-Hodgkin lymphoma (NHL), which accounts for approximately 5% of all NHL. Novel agents and rituximab maintenance therapy (RM) have greatly improved patient outcomes,[1][1],[2][2] but most patients still experience recurrent relapses. This
Keywords:
value 18f;
prognostic value;
mantle cell;
18f fdg;
cell lymphoma
Journal Title: Haematologica
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Haematologica
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!